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Abstract
Tracheal glands (TG) may play a specific role in the pathogenesis of cystic fibrosis (CF), a disease due to mutations in the cftr
gene and characterized by airway inflammation and Pseudomonas aeruginosa infection. We compared the gene expression
of wild-type TG cells and TG cells with the cftr DF508 mutation (CF-TG cells) using microarrays covering the whole human
genome. In the absence of infection, CF-TG cells constitutively exhibited an inflammatory signature, including genes that
encode molecules such as IL-1a, IL-b, IL-32, TNFSF14, LIF, CXCL1 and PLAU. In response to P. aeruginosa, genes associated
with IFN-c response to infection (CXCL10, IL-24, IFNcR2) and other mediators of anti-infectious responses (CSF2, MMP1,
MMP3, TLR2, S100 calcium-binding proteins A) were markedly up-regulated in wild-type TG cells. This microbicidal signature
was silent in CF-TG cells. The deficiency of genes associated with IFN-c response was accompanied by the defective
membrane expression of IFNcR2 and altered response of CF-TG cells to exogenous IFN-c. In addition, CF-TG cells were
unable to secrete CXCL10, IL-24 and S100A8/S100A9 in response to P. aeruginosa. The differences between wild-type TG
and CF-TG cells were due to the cftr mutation since gene expression was similar in wild-type TG cells and CF-TG cells
transfected with a plasmid containing a functional cftr gene. Finally, we reported an altered sphingolipid metabolism in CF-
TG cells, which may account for their inflammatory signature. This first comprehensive analysis of gene expression in TG
cells proposes a protective role of wild-type TG against airborne pathogens and reveals an original program in which anti-
infectious response was deficient in TG cells with a cftr mutation. This defective response may explain why host response
does not contribute to protection against P. aeruginosa in CF.
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Introduction
Cystic fibrosis (CF), the most common fatal hereditary disease in
the Caucasian population, is due to mutations in the Cystic
Fibrosis Transmembrane conductance Regulator (cftr) gene. Over
1500 mutations have been described and the most frequent of
these is a phenylalanine deletion in position 508 (DF508) (http://
www.genet.sickkids.on.ca/cftr mutations). CF is characterized by
exocrine gland alteration in multiple organs, but its major
manifestation is chronic lung disease due to airway inflammation
and bacterial colonization [1]. The precise relationship between
cftr mutations and the development of lung disease has yet to be
determined. The lungs of CF newborns exhibit abnormal mucus
secretion [2], and early inflammatory responses are present in the
airways of CF fetuses and newborns [3,4]. The excessive
production of interleukin (IL)-1, IL-6 and IL-8 by epithelial cells
with a mutated cftr gene [5–7] also suggests that an unrestricted
inflammatory reaction occurs in the airways of CF patients. This
excessive inflammatory reaction is not protective against oppor-
tunistic pathogens such as Pseudomonas aeruginosa, a gram-negative
bacterium that usually does not infect the lungs of healthy
individuals, but is largely responsible for airway obstruction and
the decline of pulmonary function in CF patients [8,9]. It has been
found that a large arsenal of products secreted by P. aeruginosa
contributes to persistent infection of the lungs of CF patients and
subsequent lung lesions [9].
Although their role is less known than that of epithelial cells
[10], tracheal glands (TG) may play a critical role in the
pathophysiology of CF [11]. TG cells express high levels of
CFTR as compared with other bronchial epithelial cell types [12],
and secrete a wide variety of proteins including mucins,
antibacterial molecules, cytokines, chemokines and lipid mediators
[13–16]. These properties would confer a role to TG in lung
homeostasis as already described for epithelial cells and in lung
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defense against infection [17]. However, the role of TG with a
functional cftr gene or the cftr DF508 mutation (CF-TG) in
pathogen persistence has not been investigated. The elevated
viscosity of TG fluid may be an important factor in promoting
airway disease and bacterial colonization [18]. Here, we took
advantage of the existence of TG and CF-TG cell lines [19,20] to
compare their gene expression profiles using microarrays covering
the entire human genome. Soluble products released by a P.
aeruginosa strain isolated from a CF patient stimulated the
expression of genes critically involved in host defense in TG cells
but not in CF-TG cells. This deficiency was related to the
impairment of the IFN-c pathway, which is essential for host
microbicidal response. Hence, the inability of CF-TG cells to
activate genes with microbicidal competence may explain why
host response does not contribute to protection against P. aeruginosa
in cystic fibrosis.
Results
Transcriptional Profile of CF-TG Cells
We analyzed the genes modulated in CF-TG cells compared to
wild-type (wt) TG cells by whole-genome microarrays. We found
that 157 genes were significantly modulated consisting of 69 up-
regulated genes and 88 down-regulated genes. The 69 up-
regulated genes in CF-TG cells (see Table S1 for the entire
microarray database) were classified by families according to their
known function (Figure 1). They are distributed in three groups of
genes. Thirty-three percent of genes (23 genes) belong to families
involved in the innate immune response (chemokines/cytokines/
growth factors, inflammatory response, matrix remodeling). They
included IL-1a, IL-1b, IL-32, TNF ligand superfamily member 14
(TNFSF14 also known as LIGHT), leukemia inhibitory factor
(LIF), CXCL1 (Gro-a) and plasminogen activator urokinase
(PLAU) (Table S1). Thirty-five percent of genes belong to the
receptor/signal transduction and transcription regulation families
and 32% of genes encoded proteins involved in unrelated cell
functions. Note that most of the up-regulated genes in CF-TG cells
exhibited a fold change (FC) lower than 3.0 (52/69 genes, Table
S1). The 88 down-regulated genes in CF-TG cells compared to wt
TG cells (see Table S2) belong to the receptor/signal transduction
and transcription regulation families (40% of the total number of
down-regulated genes) while 58% of these genes encoded
molecules involved in adhesion, cytoskeletal architecture, cell
communication, transport and ion transport, cell cycle, prolifer-
ation, metabolism and protein degradation. Only two genes
involved in the innate immune response were down-regulated
(Figure 1). These results showed that the transcriptional profile of
CF-TG cells was moderately inflammatory compared to that of wt
TG cells.
Proteins Released by P. aeruginosa strains
The bacterial strain isolated from one CF patient and the
reference PAO1 strain were cultured overnight, and the
extracellular products were analyzed by electrophoresis. The two
protein profiles were markedly different (Figure 2). Some proteins
were released only by the PAO1 strain (Table 1). This is the case
for elastase, LasB, (upper arrow, Figure 2), the Type 2 secretion
system (T2SS) Xcp classical substrate that is the major secreted
protein and band 12 (lower arrow, Figure 2), which corresponds to
the peptide (about 20 kDa) cleaved from the proenzyme LasB
before activation. Other proteins, including OprF (bands 11 and
18) and a probable T2SS substrate since it is absent in a DxcpDxqh
mutant [21], result confirmed by one of us (G. Michel in SdB’s
team, personal unpublished data) (bands 3 and 10), were released
Figure 1. Functional categories of genes in CF-TG cells. The genes expressed by wt TG and CF-TG cells were analyzed by microarrays. Up-
regulated and down-regulated genes in CF-TG cells compared to wt TG cells were classified in families according to their known function. The major
biological processes are represented by wedges, including the percentage of 69 up-regulated and 88 down-regulated genes.
doi:10.1371/journal.pone.0005357.g001
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by both strains (Table 1). Finally, different proteins were released
only by the CF strain. They included bands 1, 2, 4–9, 13, 14
(surprisingly, FliC was only detected in extracellular products of
the CF strain), 15 and 17 (Table 1). The band 17 corresponds to
the Hcp1 protein of the T6SS that has been detected in sputum of
CF patients [22]. The band 9 (PstS extracellular phosphate-
binding protein), recently described to form PstS-rich appendages
through the T2SS HxC apparatus, is induced during phosphate
limitation, thus playing a key role in P. aeruginosa virulence assessed
in a murine model [23]. Bands 6–8 and band 13, a mixture of at
least two proteins, are classically produced under phosphate
limitation as PstS. This protein pattern suggests that the phosphate
limitation-like secretome of the CF bacterial strain is remarkedly
stable even after bacterial culture. As the CF bacterial strain is
more relevant than the reference strain for investigation of
glandular response in the context of CF, we performed further
experiments with extracellular products from the clinical P.
aeruginosa CF strain.
Transcriptional Profile of wt TG and CF-TG Cells in
Response to P. aeruginosa
We wondered whether P. aeruginosa-secreted products affected
the transcriptional response of wt TG cells and CF-TG cells. First,
P. aeruginosa-secreted products significantly up-regulated the
expression of 78 genes (see Table S3, and Figure 3) in wt TG
cells compared to unstimulated wt TG cells. For the majority of
these genes (52), the FC value was higher than 3.0 and could reach
a 50-fold increase (Table S3). Forty-three percent of the up-
regulated genes encode proteins involved in the innate immune
response, 34% of genes belong to receptor/signal transduction and
transcription regulation families, and 23% of genes encode
proteins involved in other biological processes (Figure 3A). P.
aeruginosa-secreted products moderately inhibited the expression of
33 genes by 1.5 to 3.0 fold (see Table S4). Among them, 48% of
genes belong to the receptor/transduction signal and transcription
regulation families and 52% of genes encode proteins involved in
adhesion, cytoskeletal architecture, cell communication, transport,
cell cycle, proliferation, metabolism, apoptosis and protein
degradation. No gene belonging to the innate immune response
family was down-modulated (Table S4 and Figure 3B).
Second, P. aeruginosa-secreted products also affected the tran-
scriptional response of CF-TG cells compared to unstimulated CF-
TG cells. The number of modulated genes (97) was similar to that
found in stimulated TG cells (111) but the level of gene modulation
was lower. Indeed, among 67 genes significantly up-regulated in
CF-TG cells, the FC value did not exceed 8 fold and was lower than
3.0 for the majority of them (52/67) (Table S5). The distribution of
these genes in functional families was similar to that of TG cells
stimulated with P. aeruginosa products (Figure 3C): 41% of them
encode proteins involved in the innate immune response, 34%
Figure 2. Analysis of protein content of the PAO1 and the CF strain supernatants. Proteins secreted by P. aeruginosa after a 18 h-culture (*)
were cut out from Coomassie blue stained gels and subjected to mass spectrometry analysis using MALDI-TOF. Arrows designate the LasB protein-
derivatives.
doi:10.1371/journal.pone.0005357.g002
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belong to receptor/signal transduction and transcription regulation
families, and 25% of genes encode molecules involved in other cell
functions. P. aeruginosa-secreted products inhibited the expression of
30 genes in CF-TG cells (Table S6); most of these genes exhibited a
FC comprised between 1.5 and 3.0. Only one inflammatory gene
was down-modulated in P. aeruginosa-stimulated CF-TG cells. As
found in wt TG cells stimulated with P. aeruginosa products, 44% of
genes belong to receptor/transduction signal and transcription
regulation families, and 53% of genes encode proteins involved in
other cell functions (Figure 3D).
Analysis of Modulated Genes in P. aeruginosa-Stimulated
Cells
Since the distribution of genes was similar in TG and CF-TG
cells stimulated with P. aeruginosa-secreted products, we wondered
which genes were commonly or specifically modulated. Using a
Venn diagram (Figure 4), we first reported an inflammatory
signature consisting of 46 genes commonly modulated in both
stimulated cell lines (grayed in tables S3, S4, S5, S6). Among them,
seven genes were also up-regulated in unstimulated CF-TG cells
(grayed in Table S1). The expression of these genes, namely those
encoding IL-1a, IL-1b, IL-32, TNFSF14, LIF, CXCL1 and
PLAU, was validated by real time RT-PCR. The fold changes
found in microarray and real-time PCR experiments related with
each other (Figure 5). Second, 59 genes were modulated in wt TG
cells stimulated with P. aeruginosa-secreted products, but not in
stimulated CF-TG cells (Figure 4). They included 17 genes
involved in the innate immune response such as those that encode
CXCL10, which was up-regulated by 49 fold, granulocyte-
macrophage colony stimulating factor (CSF2), IL-24, matrix
metalloproteinases (MMP1 and MMP3), IFN-c receptor (IFNcR2)
and toll-like receptor (TLR2). We called this group of genes
microbicidal signature. The expression of three genes encoding
S100 calcium-binding proteins A was also up-regulated. Real time
RT-PCR confirmed the data obtained with the microarray
approach. P. aeruginosa-secreted products strongly induced the
expression of the genes encoding CXCL10, IL-24, TLR2,
IFNcR2 and S100A8 in wt TG cells, but weakly in CF-TG cells.
The differences between the FC found in wt TG cells and CF-TG
cells were significant (P,0.05) (Figure 6, compare lines 1 and 2).
Since S100A8 forms a heterodimer with S100A9 (calprotectin)
[24], we also studied the expression of the gene encoding S100A9.
This gene was significantly (P,0.05) higher in wt TG cells
stimulated with P. aeruginosa products than in stimulated CF-TG
cells (Figure 6). Third, 49 genes were modulated in CF-TG cells
stimulated with P. aeruginosa products but were unaffected in
stimulated wt TG cells (Figure 4). Among them, 11 were involved
in the innate immune response. They included the genes that
encoded IL-8, CXCL2, IL-1 receptor antagonist (IL1RN), a
powerful immunoregulatory molecule, lipocalin (LCN2) and
serum amyloid (SAA1 and SAA2) (compare Tables S5 and S3).
Taken together, these results showed that CF-TG cells stimulated
with P. aeruginosa products exhibited a specific transcriptional
program in which microbicidal signature was defective.
Table 1. Secretomes of the P. aeruginosa strains.
Numbers on gel PA Name Function MW (kDa) PAO1 strain CF strain
1 PA4270 DNA-directed RNA
polymerase beta chain
151 2 ++
2 ND ND ND 110 2 ++
3 and 10 PA0572 hypothetical protein unknown function probable T2SS substrate 100 + ++
4 PA4266 Elongation factor G 78 2 ++
5 PA4761 DnaK protein 68 2 ++
6 PA3319 PlcN non-hemolytic phospholipase C precursor 77 2 ++
7 PA2635 Hypothetical protein PhoX, predicted phosphatase 74 2 ++
8 PA0347 GlpQ glycerophosphoryl diester phosphodiesterase,
periplasmic
42 2 ++
9 PA5369 PstS phosphate ABC transporter, periplasmic
phosphate-binding protein, PstS
34 2 ++
10 and 3 PA0572 hypothetical protein unknown function probable T2SS substrate 100 + ++
11 and 18 PA1777 OprF major porin and structural outer membrane
OprF precursor
38 + ++
12 PA3724 LasB prepeptide of LasB 21 + 2
13 PA3770 GuaB inosine-59-monophosphate dehydrogenase 52 2 +
13 PA3910 hypothetical protein phosphodiesterase/alkaline phosphatase D 59 2 +
14 PA1092 FliC flagellin type B 49 2 +++
15 PA4385 GroEL chaperones & heat shock proteins 57 2 +
16 PA2623 Icd isocitrate dehydrogenase 46 + 2
17 PA0085 Hcp1 type VI secretion system effector, Hcp1 family 17 2 +
18 and 11 PA1777 OprF major porin and structural outer membrane
OprF precursor
38 + ++
Proteins secreted by the P. aeruginosa strain isolated from the patient with CF (CF strain) and the PAO1 strain were cut out from Coomassie blue stained gels and
subjected to mass spectrometry analysis using MALDI-TOF. PA is the gene number on genome annotation available at http://www.pseudomonas.com. ND: not
determined due to undetectable ions.
doi:10.1371/journal.pone.0005357.t001
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Transcriptional Program and cftr Mutation
We wondered if the transfection of CF-TG cells with a plasmid
containing a functional cftr gene induced a transcriptional pattern
similar to that of wt TG cells. First, we assessed the expression of
genes encoding IL-1a, IL-1b, IL-32, TNFSF14, LIF, CXCL1 and
PLAU, which represented the constitutive inflammatory signature
of CF-TG cells, by real-time quantitative RT-PCR (qRT-PCR).
We clearly demonstrated that the cftr gene transfer corrected the
constitutive inflammation of CF-TG cells. Indeed, the ratio of the
gene expression levels of cftr-transfected CF-TG cells and wt TG
cells was near 1, while it was significantly increased in CF-TG cells
compared to wt TG cells (Table 2). In contrast, the transfection of
CF-TG cells with a control plasmid did not affect the gene
expression of CF-TG cells (data not shown). Second, we selected 6
genes from the microbicidal signature that were up-regulated in wt
TG cells stimulated with P. aeruginosa products but not in
stimulated CF-TG cells, namely the genes that encode CXCL10,
IL-24, TLR2, IFNcR2, S100A8 and S100A9. When CF-TG cells
were transfected with a functional cftr gene and stimulated with P.
aeruginosa-secreted products, they expressed the transcriptional
signature characteristics of wt TG cells stimulated with P. aeruginosa
products. Indeed, the FC of the genes encoding CXCL10, IL-24,
IFNcR2, TLR2, S100A8 and S100A9 were significantly (P,0.05)
higher in cftr-transfected CF-TG cells than in CF-TG cells, and
were near of those of the genes expressed by wt TG cells
stimulated with P. aeruginosa products (Figure 6). Again, the
transfection of CF-TG cells with a control plasmid did not modify
the gene expression of CF-TG cells in response to P. aeruginosa
products (data not shown). Taken together, these results
demonstrated that the constitutive inflammatory program and
Figure 3. Functional categories of genes in stimulated TG cells. The genes expressed by wt TG and CF-TG cells stimulated with P. aeruginosa-
secreted products were analyzed by microarrays. Up-regulated and down-regulated genes were classified in families according to their known
function. The major biological processes are represented by wedges, including the percentage of modulated genes. Seventy eight genes were up-
regulated (A) and 33 genes were down-regulated (B) in stimulated wt TG cells; 67 genes were up-regulated (C) and 30 genes were down-regulated
(D) in stimulated CF-TG cells.
doi:10.1371/journal.pone.0005357.g003
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the defective microbicidal signature of CF-TG cells were related to
the cftr DF508 mutation.
Functional Analyses of Inflammatory and Microbicidal
Signatures of CF-TG cells
Since the expression of the genes that encode IL-1a, IL-b, LIF
and CXCL1 was higher in CF-TG cells when compared to that of
wt TG cells, we wondered whether the spontaneous release of
these inflammatory mediators after 24 h of culture was also
increased in CF-TG cells. The cytokine content of cell
supernatants was determined by ELISA. The spontaneous release
of IL-1a, IL-b, LIF and CXCL1 was significantly (P,0.05)
increased in CF-TG cells (Table 3), demonstrating that the
transcriptional inflammatory signature of CG-TG cells corre-
sponded to a functional signature.
Next, we tempted to relate the silencing microbicidal signature
in CF-TG cells with the expression of effectors. First, we studied
the release of CXCL10, IL-24, S100A8/S100A9 and TNFSF14
by wt TG cells and CF-TG cells stimulated with P. aeruginosa-
secreted products by ELISA. P. aeruginosa products were unable to
stimulate the release of CXCL10, IL-24, S100A8/S100A9 and
TNFSF14 by CF-TG cells but clearly stimulated their secretion by
wt TG cells (Figure 7). This inability of CF-TG cells to produce
cytokines in response to P. aeruginosa-secreted products was specific
of cytokines involved in microbicidal response. Indeed, the release
of IL-1a and LIF was significantly increased (P,0.05) in CF-TG
cells stimulated with P. aeruginosa products compared to resting CF-
TG cells (4950650 vs. 42006140 pg/26106 cells for IL-1a;
425642 vs. 4567 pg/26106 cells for LIF). Second, the mem-
brane expression of IFNcR2 and TLR2 proteins by wt and CF-
TG cells was studied by flow cytometry. Clearly, the membrane
expression of IFNcR2 and TLR2 was lower in CF-TG cells
stimulated with P. aeruginosa-secreted products than in stimulated
wt TG cells (Figure 8A). The defective expression of IFNcR2 had
functional consequences. Indeed, the treatment of wt TG cells
with human recombinant IFNc resulted in the increased
expression of genes encoding IFNcR2, IL-24 and CXCL10. In
contrast, IFNc was unable to stimulate their expression in CF-TG
cells (Figure 8B), suggesting that CF-TG cells were unable to
mount a microbicidal program even in response to IFNc.
Altered Sphingolipid Pathway in CF-TG cells
It has been recently shown that altered metabolism of
sphingolipids due to defective acidification of intracellular vesicles
might account for constitutive inflammation of lungs from cftr-
Figure 4. Venn diagram of differentially gene expression. A
total of 157 modulated genes in CF-TG cells, 111 in wt TG cells
stimulated with P. aeruginosa-secreted products and 98 in CF-TG cells
stimulated with P. aeruginosa products were compared. Intersection
showed 46 genes modulated within wt TG and CF-TG cells stimulated
with P. aeruginosa-secreted products, and 10 genes were common in
the three groups of cells.
doi:10.1371/journal.pone.0005357.g004
Figure 5. Validation of seven target sequences using qRT-PCR.
The expression levels of seven genes commonly regulated by CF-TG
cells and wt TG cells stimulated with P. aeruginosa-secreted products
were determined by microarray (white bar) and qRT-PCR (black bar).
The results of microarrays are expressed as the log2 ratio of the fold
change, and the results of qRT-PCR represent means6SEM of three
experiments performed in triplicate. (1) unstimulated CF-TG cells vs.
unstimulated wt TG cells; (2) stimulated vs. unstimulated wt TG cells; (3)
stimulated vs. unstimulated CF-TG cells.
doi:10.1371/journal.pone.0005357.g005
Tracheal Gland Cells
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deficient mice [25]. We wondered if such mechanism was found in
CF-TG cells and may account for their inflammatory signature.
First, the analysis of microarray data suggests an imbalance in
sphingolipid metabolism. It revealed that the expression of
galactosyl-ceramidase was down-regulated in CF-TG cells com-
pared to wt TG cells (Table S2). Several key components of the
ceramide metabolism are represented in the network of modulated
genes in CF-TG cells (Figure 9). They included the enzymes
involved in the sphingomyelin degradation pathway, i.e. sphyngo-
myelin phosphodiesterase 1 (SMPD1), N-acylsphingosine amido-
hydrolase 2 (ASAH2), sphingosine kinase (SPHK) 1 and 2.
Interestingly, SMPD1, ASAH2 and downstream genes were
down-modulated in CF-TG cells as compared to wt TG cells. In
contrast, genes encoding SPHK1 and related genes were up-
regulated. Note that several transcription factors, including SP1,
SP3 and CTNND1, were down-regulated in CF-TG cells
compared to wt TG cells and that the SFTPB gene encoding
the SP-B protein involved in the reduction of pulmonary
surfactant properties [26] was up-regulated in CF-TG cells.
Second, sphingolipids were quantified in wt TG and CF-TG cells.
Galactosyl-ceramides (galactocerebrosides) were significantly
(P,0.01) increased in CF-TG cells as compared to wt TG cells
while ceramide levels were similar in CF-TG cells and wt TG cells
(Figure 10). Third, wt TG cells were treated with bafilomycin A1
and chloroquine to alkalinize intracellular vesicles, and the
inflammatory signature of wt TG cells was determined. Bafilomy-
cin A1 used at 300 nM significantly increased the expression of
genes encoding IL-1a, IL-1b, IL-32, TNFSF14, LIF, CXCL1 and
PLAU (Figure 11A). Chloroquine at 200 mM also increased the
expression of the inflammatory signature of wt TG cells
(Figure 11B). Doses of 30 nM of bafilomycin A1 and 20 mM of
chloroquine did not affect the expression of inflammatory genes in
wt TG cells (data not shown). Taken together, these results suggest
that altered metabolism of sphingolipids and defective acidification
of intracellular organelles may account for the inflammatory
signature of CF-TG cells.
Discussion
We wondered whether TG may play a role in airway defense
against P. aeruginosa since they are known to secrete a wide variety
of molecules involved in bacterial defense [13–16] and that the
increased viscosity of TG fluid in CF may favor bacterial infection
[18]. We first selected a P. aeruginosa strain, which was the first
strain from clone A lineage isolated from a DF508 homozygous
Figure 6. Impaired immune response in P. aeruginosa-stimulat-
ed CF-TG cells. The expression levels of six genes involved in the
innate immune response were studied by qRT-PCR. Results, which
represent means6SEM of three experiments performed in triplicate, are
expressed as fold change. (1) stimulated vs. unstimulated wt TG cells; (2)
stimulated vs. unstimulated CF-TG cells; (3) stimulated vs. unstimulated
cftr-transfected CF-TG cells. *P,0.05.
doi:10.1371/journal.pone.0005357.g006
Table 2. Inflammatory program of CF-TG cells transfected
with cftr gene.
Gene fold change
CF-TG cells/wt TG cells
cftr-transfected CF-TG
cells/wt TG cells
IL-1a 4.360.4 1.260.1*
IL-1b 4.560.7 1.660.3*
IL-32 4.660.7 1.760.4*
TNFSF14 2.160.2 1.760.1
LIF 2.760.2 0.860.1*
CXCL1 3.760.2 0.760.05*
PLAU 2.960.1 0.860.1*
The expression levels of seven commonly regulated genes were determined by
qRT-PCR. The results are expressed as the fold changes between CF-TG cells and
wt TG cells, and between CF-TG cells transfected with cftr gene and wt TG cells.
They represent means6SEM of three experiments.
*P,0.05.
doi:10.1371/journal.pone.0005357.t002
Table 3. Release of inflammatory cytokines by TG cells.
Cytokines wt TG cells CF-TG cells
IL-1a 19756125 42006150*
IL-1b 0.03560.015 2.560.15*
LIF 0 4566.5*
CXCL1 4200685 75006375*
The spontaneous release of inflammatory cytokines by wt TG cells and CF-TG
cells was determined by ELISA. The results are expressed in pg per 26106 cells.
They represent means6SEM of three experiments.
*P,0.05.
doi:10.1371/journal.pone.0005357.t003
Tracheal Gland Cells
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patient. As bacteria do not reach the bronchial epithelium but
rather stick in the viscous mucus overlaying the epithelium
[27,28], we chose to use extracellular products released by P.
aeruginosa but not viable bacteria. It is likely that these released
products reach glands from the epithelium surface since these two
compartments are connected through connecting tubes. In
addition, it has been demonstrated that the rhinovirus infection
of submucosal gland cells induces mucin production [29].
Consequently, we stimulated TG cells with products secreted by
a strain of P. aeruginosa isolated from a patient with CF.
We found that P. aeruginosa-secreted products stimulated a
microbicidal response in wt TG cells dependent, at least in part, on
the IFN-c pathway. First, the expression of genes encoding
mediators such as CXCL10, IL-24, TLR2, IFNcR2 and S100
calcium-binding proteins A was up-regulated. CXCL10 (interfer-
on-gamma-inducible protein 10, IP10) is a target of the IFN-c
pathway [30]. IL-24 is able to stimulate IFN-c production by
mononuclear cells besides its major role in wound healing and cell
proliferation [31]. Second, the expression of the receptor of IFN-c
(IFNcR2) by wt TG cells was increased in response to P. aeruginosa-
secreted products. Third, adding IFNc to wt TG cells up-regulated
the expression of genes encoding IFNcR2, IL-24 and CXCL-10,
suggesting that the IFNc pathway plays a major role in the
microbicidal response of wt TG cells to P. aeruginosa products. The
increased membrane expression of TLR2 by wt TG cells in
response to P. aeruginosa-secreted products may also participate to
innate immune response. It has been demonstrated that TLR2
recognizes P. aeruginosa [32] and that this pathogen activates
airway epithelial cells through recognition by TLR2 [33]. The
expression of S100 calcium-binding proteins A8 (Mrp8) and A9
(Mrp14) was also markedly up-regulated in TG cells. These
proteins display potent antimicrobial activity [24,34], and are
expressed in bronchial epithelial cells exposed to P. aeruginosa [35].
S100A8 and S100A9 also interact with TLR4 to amplify
phagocyte activation [36], and are under the control of IL-10
family members [37]. Finally P. aeruginosa-secreted products
dramatically increased the release of TNFSF14 by wt TG cells.
TNFSF14 is known to be expressed by T lymphocytes [38] and
dendritic cells [39]. TNFSF14 that belongs to the TNF
superfamily is involved in inflammation and immune response
through its role on IFN-c [40] and IL-12 [41] production. To our
knowledge, this is the first demonstration that TNFSF14 is
secreted by wt TG cells.
We also found that numerous genes including inflammatory
genes were constitutively up-regulated in CF-TG cells compared
to wt TG cells. The moderate inflammatory signature of CF-TG
cells consisted of inflammatory cytokines such as IL-1 family
members and CXCL1 (Gro-a), known to be associated with CF
[42,43], and inflammatory genes not previously associated with
the disease such as IL-32, TNFSF14, LIF and PLAU. IL-32, a
cytokine recently described, induces the expression of TNF, IL-1,
IL-6 and chemokines [44,45]. LIF, which may act as a pro- or
anti-inflammatory cytokine, has an important role in chronic
airway inflammation [46] and stimulates the production of
chemotactic factors by monocytes [47]. PLAU is involved in
inflammation and matrix remodeling with ADAM8 or SERPIN,
and might induce gland hyperplasia [48]. We can suppose that the
up-regulation of PLAU or associated genes is related to the
hyperplasia found in CF airways [49]. Note that a potential
secreted virulence factor from P. aeruginosa degrades PLAU
receptor [50], suggesting that the PLAU pathway is critical in
host response to bacterial aggression. The constitutive inflamma-
tory signature observed in CF-TG cells was due to the cftr DF508
mutation since the transfection of CF-TG cells with a plasmid
containing a functional cftr gene prevented the up-regulation of
inflammatory genes. Our results are consistent with the hypothesis
that early pulmonary inflammation is already present before any
infection in CF lungs [3,4,51]. They also suggest that the role of
tracheal glands is critical in the pathophysiology of CF. First, CF is
characterized by altered exocrine glands and it is likely that TG
cells express higher levels of CFTR than other bronchial epithelial
cells [12]. Second, our results clearly showed that the cftr DF508
mutation is related to up-regulated expression of inflammatory
genes in CF-TG cells. In airway epithelial cells from the trachea or
bronchi of CF donors, it has been shown that the cftr DF508
mutation has a minimal effect on the expression profile of <
22,000 genes: only 18 genes were up-regulated. They include nine
genes of unknown function and eight genes involved in
transcription regulation, adhesion, cytoskeleton/cell communica-
tion, ion transport/transport and metabolism. Only one gene,
which encodes a novel interleukin receptor, may be included in the
inflammatory family [52].
Importantly, we demonstrated that P. aeruginosa-secreted prod-
ucts were unable to induce a microbicidal response in CF-TG cells
in contrast to wt TG cells. Hence, genes from the IFN-c pathway
(IL-24, CXCL10 and IFNcR2) and other mediators of innate
immune response such as TLR2, S100A8 and S100A9 were not
modulated. The lack of IFN-c signaling due to a mutation in the
extracellular domain of IFNcR2 is associated with susceptibility to
mycobacterial infection [53]. CF-TG cells also exhibited defective
membrane expression of IFNcR2 after stimulation with P.
Figure 7. Release of cytokines of the innate immune response
by TG cells. Wild type TG and CF-TG cells (26106 cells per assay) were
incubated in the absence (white bar) or presence (black bar) of P.
aeruginosa-secreted products for 24 h. The release of cytokines of the
innate immune response by wt TG cells (1) and CF-TG cells (2) was
determined by ELISA. The results are expressed in pg of cytokines. They
represent means6SEM of three experiments. *P,0.05. NS: non
significant.
doi:10.1371/journal.pone.0005357.g007
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aeruginosa products. Adding IFNc to CF-TG cells did not stimulate
the expression of genes from IFNc pathway, in contrast to wt TG
cells. The defective membrane expression of TLR2 by CF-TG
cells may participate to decreased innate immune response. It is
likely that the defective expression of TLR2 and the lack of
calcium-binding proteins A combined with impaired IFN-c
pathway account for the inefficiency of the innate immune
response toward P. aeruginosa in CF-TG cells. TNFSF14 may also
be involved in defective response of CF-TG cells to P. aeruginosa-
secreted products. Its blockade induces susceptibility of mice to
Leishmania major through the down-modulation of IL-12 [41],
suggesting that TNFSF14 may be a critical factor in the P.
aeruginosa susceptibility of cells with a cftr gene mutation.
The differences in the constitutive inflammatory signature and
the microbicidal responses induced by P. aeruginosa products
between CF-TG cells and wt TG cells may be due to genetic and
phenotypic differences since both cell lines have been isolated and
established from two different donors. This was unlikely since we
found that CF-TG cells exhibited an inflammatory pattern, as
previously reported for CF epithelial cells [1,3,4]. Importantly, we
clearly showed that the constitutive inflammatory signature of CF-
TG cells and the impaired expression of genes involved in
microbicidal responses induced by P. aeruginosa-secreted products
were exclusively dependent on the cftr DF508 mutation. Indeed,
the transfection of CF-TG cells with the cftr gene corrected their
transcriptional profile toward a profile similar to that of wt TG
Figure 8. Receptor expression, and effect of IFNc on gene expression in CF-TG cells. A, wt TG and CF-TG cells were incubated in the
absence or presence of P. aeruginosa-secreted products for 24 h. The membrane expression of IFNcR2 and TLR2 was determined by flow cytometry.
Histograms are representative of three different experiments. Hatched line, control IgG; Full line, unstimulated cells; Grey color, cells stimulated with
P. aeruginosa-secreted products. B, 1000 UI of IFNc were added to wt TG cells (1) and CF-TG cells (2) for 3 h, and the expression of genes encoding
IFNcR2, Il-24 and CXCL10 was studied by qRT-PCR. Results, which represent means6SEM of three experiments, are expressed as fold change. (1) IFNc-
treated vs. untreated wt TG cells; (2) IFNc-treated vs. untreated CF-TG cells.
doi:10.1371/journal.pone.0005357.g008
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cells. In a previous study, it has also been shown that the transfer of
a functional cftr gene to CF-TG cells corrects defective secretory
function [54]. These results clearly demonstrated that both
inflammatory and non-microbicidal signatures of CF-TG cells
were related to the expression of the cftr gene.
Finally, it has been recently demonstrated in cftr-deficient mice
that sphingolipids are involved in CF pathogenesis through altered
pH of intracellular vesicles [25]. We showed here that sphingolipid
metabolism was altered in human CF-TG cells. Indeed, the
analysis of microarray data showed that ceramidase and numerous
related genes were down-modulated whereas sphingosine kinase
and other related genes were up-regulated in CF-TG cells
compared to wt TG cells. Ceramide is critical in sphingolipid
metabolism. It is generated from sphingomyelin by the action of
acid sphingomyelinase or de novo synthesis through the ceramide
synthase. It may be transformed into sphingosine, ceramide-1-
phosphate, glucosylceramide by different enzymes, and sphingo-
myelin in the Golgi apparatus. Ceramide may also be glycosylated
in galactosyl-ceramide by a galactosyl-ceramide synthase that
transfers galactose from a UDP-galactose donor [55]. We showed
that galactosyl-ceramide accumulated in CF-TG cells compared to
wt TG cells whereas the ceramide levels were similar in wt TG and
CF-TG cells. Note that bacteria such as Escherichia coli [56] and
Helicobacter pylori [57] selectively interact with galactosyl-ceramide,
Figure 9. Analysis of genes of the sphyngolipid pathway in wt TG and CF-TG cells. Microarray data were collected, and the network of
genes encoding enzymes involved in the sphyngolipid metabolism and predicted target genes that are significantly modulated was represented. Red
color corresponded to up-regulated genes in CF-TG cells compared to wt TG cells and blue color to down-regulated genes.
doi:10.1371/journal.pone.0005357.g009
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suggesting that increased levels of galactosyl-ceramide may favor
the binding of P. aeruginosa to CF-TG cells. In cftr-deficient mice,
ceramide accumulation is observed in the respiratory tract
epithelium and submucosa [25]. The apparent discrepancies
between our results and those of Teichgra¨ber et al. [25] may be
explained by the different methods of ceramide determination, the
complex regulation of the ceramide pathway and the different cell
types. Hence, alveolar epithelial cells of cftr-deficient mice do not
accumulate ceramide [25]. Defective acidification of organelles in
CF cell types may alter sphingolipid metabolism and, as a
consequence, the expression of proinflammatory cytokines [25].
We reasoned that pH neutralization of vesicles may increase the
expression of inflammatory genes in wt TG cells. For that purpose,
we used bafilomycin A1, a specific inhibitor of V-ATPase involved
in vesicle acidification and chloroquine, a weak base that
diminishes CpG signaling by neutralizing endosomal pH [58].
The genes that encode the seven cytokines of the inflammatory
signature of CF-TG cells were up-regulated in wt TG cells treated
by alkalinizing agents compared to untreated wt TG cells. This
result extended the observation that defective CFTR leads to
defective acidification of intracellular organelles [25,59]. It also
demonstrated a functional link between pH rise and inflammatory
cytokines independently of CF.
In conclusion, our study represents the first comprehensive
analysis of gene expression in TG cells. It reveals an original
program consisting of a constitutive and moderate inflammatory
state of CF-TG cells likely due to altered sphingolipid metabolism.
Defective microbicidal responses to P. aeruginosa of CF-TG cells
were related, at least in part, to defective IFN-c pathway. The
inflammatory signature and the defective microbicidal signature of
CF-TG cells were corrected when CF-TG cells were transfected
with a functional cftr gene. They may be sufficient to account for
host inefficiency in struggle against P. aeruginosa in cystic fibrosis.
The candidate genes non-previously reported may serve as targets
for new therapeutic approaches.
Materials and Methods
P. aeruginosa
The strain used in this study was isolated from a CF patient with
a cftr DF508/DF508 genotype associated with an exocrine
pancreatic insufficiency. It was the first isolated strain in sputum
from this CF patient who was 16.2 years old at the time of
collection. The strain belongs to the clone A lineage and has
functional type IVa and flagellum tested by twitching and
swimming mobility, respectively (data not shown). Single colonies
isolated from CF and PAO1 reference [60] strains were grown in
LB to a stationary phase at 37uC for 18 h. Bacterial suspensions
(26109 cfu/ml) were centrifuged at 3,0006g for 15 min, and
supernatant from the CF strain was further filtered through
0.2 mm filters and used to stimulate TG cells. Filtered LB was used
as negative control.
Analysis of P. aeruginosa products
P. aeruginosa-secreted products were submitted to tetraacetic acid
precipitation for electrophoretic analysis and protein content
determination. An equivalent of 0.025 OD600 units/ml was added
to SDS-PAGE loading buffer. The samples were boiled for 10 min
and the proteins separated by electrophoresis on a 12%
polyacrylamide gel. The proteins were stained with Coomassie
blue, cut out, subjected to procedures routinely performed in the
proteomic platform at the IBSM (http://www.ibsm.cnrs-mrs.fr/
ifrc/servtech/seq) and analyzed by mass spectrometry. Briefly,
Figure 10. Ceramide levels in wt TG cells and CF-TG cells. Total
lipids were extracted from wt TG cells (1) and CF-TG cells (2), and
separated by one-dimensional thin-layer chromatography. Galactosyl-
ceramides and ceramides were quantified by scanning using standard
calibration curves (r2). The results, which represent means6SEM of 5
determinations, are expressed in mg galactosyl-ceramide (A) or
ceramide (B) per mg of total lipids. *P,0.05.
doi:10.1371/journal.pone.0005357.g010
Figure 11. Role of alkalinization on the inflammatory signature
of wt TG cells. Wild type TG cells were treated with 300 nM
bafilomycin A1 (A) or 200 mM chloroquine (B) for 3 h. The expression
levels of the seven genes involved in the inflammatory signature of CF-
TG cells were studied by qRT-PCR. Results are expressed as the log2
ratio of the fold change observed in the presence of alkalinization agent
vs. in its absence. They represent the means6SEM of three experiments.
doi:10.1371/journal.pone.0005357.g011
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samples were treated via reduction and alkylation processes,
digested with trypsin, desalted and subjected to mass spectrometry
analysis using MALDI-TOF. Internal scale up was done with ions
coming from trypsin autolysis and keratin. Mass values were
compared with theoretical values from peptides referenced in
databases.
Cell culture
The serous tracheal gland cell lines MM39 (TG cells) and CF-
KM4 (CF-TG cells) were isolated from a healthy donor [20] and a
CF patient with a cftr DF508/DF508 mutation [19], respectively.
Cell cultures were carried out as previously described [20,61]. In
brief, cells were maintained in Dulbecco’s modified Eagle’s/Ham’s
F12 medium (Sigma Chemicals) supplemented with 0.1% Ultroser
G (Biosepra), 5% adult bovine serum, 5 g/l D-glucose and 0.1 g/l
pyruvate. The absence of mycoplasma in cell cultures was checked
using the VenorGeM kit (Biovalley). In some experiments, CF-TG
cells were transfected with the pcDNA3-CFTR plasmid (Trans-
ge`ne, Strasbourg, France) or with the pM1-LUC plasmid (Roche
Molecular Biology) as a negative control using the Lipofectamine
Reagent (Invitrogen) as previously described [54]. Cells plated in
12-well tissue culture dishes (Falcon) were stimulated with P.
aeruginosa-secreted products (1:10 dilution) for 3 h for transcrip-
tional studies, as described elsewhere [62], or 24 h for functional
studies. In some experiments, 1000 UI of human recombinant
IFNc (Peprotech) were added to wt TG and CF-TG cells for 3 h
before transcriptional analyses by real-time quantitative RT-PCR
(qRT-PCR) (see below). The alkalinization of intracellular
organelles was performed as previously described [58]. Wild type
TG cells were incubated with different concentrations of
bafilomycin A1 or chloroquine (Sigma) for 3 h, and the expression
of inflammatory genes was studied by qRT-PCR.
Microarrays and data analysis
Total RNA was extracted using the RNeasy minikit (Qiagen)
and DNAse treatment. The quality and the quantity of RNA
preparation were assessed using the 2100 Bioanalyzer and the
RNA 6000 Nano LabChip kit (Agilent Technologies). The 4644 k
Human Whole Genome microarrays (Agilent Technologies)
representing 33,581 genes or transcripts were used. Sample
labeling and hybridization were performed according to protocols
specified by the manufacturer (One-Color Microarray-Based
Gene Expression Analysis). Briefly, 300 ng of total RNA and
cyanine 3-labeled CTP (Cy-3) fluorescent dyes were used to
generate fluorescent cRNA with Low RNA Input Fluorescent
Amplification Kit (Agilent Technologies). Hybridization was
performed for 17 h at 65uC using the In situ Hybridization Kit
Plus (Agilent Technologies). All processing steps were performed in
an ozone-controlled environment ([O3] ,2 ppb). Twelve samples
with three samples per cell group were included in the analysis.
Slides were scanned at a 5 mm resolution with a G2505B DNA
microarray scanner (Agilent Technologies). Image analysis and
intra-array signal correction were performed using Agilent Feature
Extractor Software A.9.1.3. Data processing, analysis and
visualizing were performed using the Resolver software 7.1
(Rosetta Inpharmatics). Its error model-based transformation
pipeline was used to map replicate reporters to genes and perform
inter-array normalization. The intensity error model and its
applications were used as described elsewhere [63]. The same
procedure was used to discriminate the genes differentially
expressed by two data groups (CF-TG cells vs. wt TG cells; wt
TG stimulated cells vs. wt TG cells, CF-TG stimulated cells vs. CF-
TG cells). Data were pre-processed by selecting only the best
known genes (21,236) and then applying filters on gene expression
level and variation among samples. Thus, a gene was kept for
further analysis when the P-value of the error model was below
0.01 in at least 3 of the 6 samples and its coefficient of variation
among samples was over 0.2. Discrimination between samples was
performed using the unpaired Student’s t test, the fold change (FC)
and its associated P-value obtained with the Resolver error-model.
A gene was considered as differentially expressed between two
groups whether it met both criteria: a P-value for 2-sided Student’s
t test below 0.01 and an absolute |FC|.1.5 with a confidence P-
value below 0.01. All data are MIAME compliant (accession
no. A-MEXP-1332; www.ebi.ac.uk/miamexpress) [64]. Results
were expressed as FC in fluorescence intensities between two
groups, and expressed in log2. Gene families were determined
using numerous databases: DAVID Bioinformatics Resources
2008 (http://david.abcc.ncifcrf.gov/), Online Medelian Inheri-
tance in Man (http://www.ncbi.nlm.nih.gov/sites/entrez?db =O-
MIM&TabCmd=Limits), SOURCE (http://smd.stanford.edu/
cgi-bin/source/sourceSearch), and Babelomics Fatigo+ (http://
babelomics2.bioinfo.cipf.es/fatigoplus/cgi-bin/fatigoplus.cgi). The
genes involved in the sphingolipid metabolism were studied using
a construction that connected the 25 entities belonging to the
sphingolipid-metabolism-process Gene Ontology group. Regula-
tory (dashed grey arrow) and physical (plain purple line)
interactions between entities was based on information extracted
from the literature using PathwayStudioTM (AriadneGenomics).
Data from microarray experiments were collected and red color
corresponded to up-regulated genes in CF-TG cells compared to
wt TG cells and blue color to down-regulated genes.
qRT-PCR
Reverse transcription of total RNA was performed according to
the manufacturer’s protocol (Invitrogen). Forward and reverse
primers were constructed according to published sequences, and
design was optimized for the LightCycler 480 System (Roche
Diagnostics) (see Table S7 for primer sequences). qRT-PCR was
performed using the LightCycler 480 SYBR Green I Master kit.
Temperature cycling proceeded as follows: 5 min at 95uC to
activate the FastStart Taq DNA Polymerase, followed by 45 cycles
each consisting of: 15 s at 95uC for denaturation, followed by 30 s
at 60uC for primer annealing and 30 s at 72uC for elongation.
Melting curve analyses were performed by increasing the
temperature from 70uC to 95uC. A standard curve for each
primer was performed to determine the amplification efficiency.
Relative quantification was calculated from the Cp values of the
targeted gene and the reference gene using the LightCycler 480
software analysis (Roche Diagnostics). The mean ratio was
calculated from triplicate assays. Each experiment was performed
three times. Results were expressed as FC between two groups.
Flow cytometry
Cells (56105 cells in 100 ml of phosphate buffered saline (PBS)
containing 10% foetal calf serum and 1% sodium azide) were
incubated with 10 ml of FITC-conjugated TLR2 (eBioscience)
antibodies (Abs) for 1 h at 4uC or with 10 ml of IFNcR2 Abs
(Santa Cruz) for 1 h followed by an incubation with 5 ml of swine
anti-human IgG-FITC Abs (R&D Systems) for 30 min at 4uC.
After washing, cells were analyzed by flow cytometry (EPICS XL,
Beckman Coulter). Fluorescence was determined on all cells for
each sample after debris, dead cells, and aggregates were excluded
by selective gating based on orthogonal and side light scatter
characteristics. Mean fluorescence intensity (MFI) was compared
with control staining using an irrelevant isotype-matched human
monoclonal antibody. For each sample, at least ten thousand
events were collected and histograms were generated per sample.
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The percentage of positive cells was determined using the Expo32
ADC and the WinMDI 2.8 software. Each experiment was
performed three times and a representative histogram is shown.
ELISA
Cells (26106 cells) were stimulated with P. aeruginosa-secreted
products for 24 h, centrifuged and supernatants were stored at
280uC before assays. The enzyme-linked immunobsorbent assays
(ELISA) were provided from Beckman Coulter for IL-1a, R&D
Systems for IL-1b, IL-24 and TNFSF14, RayBiotech for LIF and
CXCL10, Preprotech for CXCL1, and Hycult Biotechnology for
S100A8/S100A9. The assays were performed according to the
manufacturer’s instructions. The detection limit of the kits was less
than 1.6 ng/ml for S100A8/S100A9, 15 pg/ml for IL-1a, LIF
and IL-24, 10 pg/ml for CXCL1, 8 pg/ml for CXCL10, 5.5 pg/
ml for TNFSF14, and 0.023 pg/ml for IL-1b. The mean ratio was
calculated from triplicate assays. Each experiment was performed
three times.
Sphingolipid metabolism
Pelleted cells (26107 cells per assay) were suspended in 1 ml of
water, and lipids were extracted by 20 ml of chloroform/methanol
(2:1 volume), as already described [65]. After evaporation of the
lipid phase under nitrogen, lipids were separated by four-stage,
one-dimensional thin-layer chromatography (TLC) using
20620 cm TLC Silica Gel G60 analytical plates (Merck),
according to Auge´ et al. [66]. For staining, plates were dipped
in 10% copper sulfate/8% phosphoric acid solution [64]. The
plates were drained and heated at 130uC for 1 h. Several standard
calibration curves were constructed with 0.5–50 mg of pure
sphingolipid species (sphingomyelin, ceramides, galactocerebro-
sides, glucocerebrosides, lactocerebrosides, 1-b-D galactosylsphin-
gosine) all species provided from Sigma. Ceramides and galactosyl-
ceramides were quantified by densitometry after scanning the
plates and using the software package Bio-1D++ (Vilber Lourmat).
Statistical analysis
Results are expressed as means6SEM and [95% CI] and
compared with the non-parametric Mann-Whitney U test.
Statistical significance of qRT-PCR data was determined using
the Student’s t test. Differences were considered significant when
P,0.05.
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